Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.13
Price to sales ratio
-613.58

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2206
REPL
Replimune Group, Inc. - Common Stock
15.50 USD-0.64%+5.95%+36.20%+180.80%1.46 B USD
2236
CGEM
Cullinan Therapeutics, Inc. - Common Stock
21.70 USD-3.98%+0.37%+25.07%+189.33%1.40 B USD
2251
ORIC
Oric Pharmaceuticals, Inc. - Common Stock
13.24 USD-3.64%-6.50%+18.43%-2.00%1.37 B USD
2264
OMER
Omeros Corporation - Common Stock
18.61 USD-3.32%-2.46%+59.74%+349.52%1.35 B USD

Frequently asked questions about Alto Neuroscience Inc.

What is the Alto Neuroscience Inc. stock price today?

The current price of Alto Neuroscience Inc. (ANRO) is 35.13. Over the past 24 hours, the stock has changed by -3.01%. Follow the ANRO chart for real-time price dynamics.

What is the stock ticker of Alto Neuroscience Inc.?

Alto Neuroscience Inc. trades under the ticker ANRO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Alto Neuroscience Inc. stock going up?

ANRO has changed by +1.24% over the last week, +32.52% over the last month, and +854.62% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Alto Neuroscience Inc.?

Alto Neuroscience Inc. currently has a market capitalization of 1.38 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Alto Neuroscience Inc. earnings last quarter?

Last quarter, Alto Neuroscience Inc. reported earnings of -0.65 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Alto Neuroscience Inc. revenue for the last quarter?

Alto Neuroscience Inc. reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Alto Neuroscience Inc. net income for the last quarter?

Alto Neuroscience Inc. reported net income of -27.64 M for the last quarter. The previous quarter showed -26.24 M, which means net income changed by -5.34%.

How many employees does Alto Neuroscience Inc. have?

As of the latest available data, Alto Neuroscience Inc. has 68 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Alto Neuroscience Inc. stock?

You can buy Alto Neuroscience Inc. (ANRO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Alto Neuroscience Inc. stock?

Investing in Alto Neuroscience Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ANRO chart and related analysis on metatrader.com as part of your research.

News